Twist Bioscience Corporation (TWST) Tops Q4 EPS by 16c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Twist Bioscience Corporation (TWST) Tops Q4 EPS by 16c, Revenues Beat

Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2020 Financial Results

November 23, 2020 7:01 AM EST

-- Fiscal 2020 Revenues of $90.1M; Increase of 66% over $54.4M in Fiscal 2019 --

-- Strong Growth in Synthetic Biology, NGS Businesses --

-- Twist Biopharma Established 13 Partnerships, 8 with Milestones and/or Royalties in FY20 --

-- Expect Revenue of $110M to $118M for Fiscal 2021 --

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business... More